Observational study of serum HER2 in HER2 positive advanced gastric cancer treated with trastuzumab in combination with capecitabine plus cisplatin(XP+H)
Latest Information Update: 27 Mar 2017
At a glance
- Drugs Capecitabine (Primary) ; Cisplatin (Primary) ; Trastuzumab
- Indications Gastric cancer
- Focus Biomarker; Pharmacodynamics
- Acronyms SHERLOCK2
- 01 Oct 2011 New trial record